Rationale and design of the EMPYREAN study

AIMS: A sodium glucose cotransporter 2 (SGLT2) inhibitor was recently found to reduce heart failure hospitalization in the EMPA‐REG OUTCOME trial. We have hypothesized that autonomic nerve activity may be modulated by SGLT2 inhibition. The current study aims to investigate the impact of empagliflozi...

Descripción completa

Detalles Bibliográficos
Autores principales: Motoki, Hirohiko, Masuda, Izuru, Yasuno, Shinji, Oba, Koji, Shoin, Wataru, Usami, Satoru, Saito, Yoshihiko, Waki, Masako, Komatsu, Mitsuhisa, Ueshima, Kenji, Nakagawa, Yasuaki, Son, Cheol, Yonemitsu, Shin, Hiramitsu, Shinya, Konda, Manako, Onishi, Katsuya, Kuwahara, Koichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Study Designs
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524086/
https://www.ncbi.nlm.nih.gov/pubmed/32578353
http://dx.doi.org/10.1002/ehf2.12825

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524086/
https://www.ncbi.nlm.nih.gov/pubmed/32578353
http://dx.doi.org/10.1002/ehf2.12825

Ejemplares similares